The innate immune system: Gatekeeper to the female reproductive tract

Immunology

Volumn 111, Issue 1, 2004, Pages 13-15

  Wira, Charles R ^a   Fahey, John V ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMNION FLUID; ANTIBACTERIAL ACTIVITY; CELL ACTIVITY; CELL SECRETION; CHLAMYDIA TRACHOMATIS; EPITHELIUM CELL; FEMALE; FEMALE GENITAL SYSTEM; FERTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; INFECTION PREVENTION; NOTE; PHAGOCYTE; PREGNANCY; PRIORITY JOURNAL; PROTECTION; SEXUALLY TRANSMITTED DISEASE; STREPTOCOCCUS AGALACTIAE; VAGINA;

ESTRADIOL; FEMALE; HUMANS; IMMUNITY, NATURAL; MEMBRANE GLYCOPROTEINS; MUCOUS MEMBRANE; PROGESTERONE; RECEPTORS, CELL SURFACE; SEXUALLY TRANSMITTED DISEASES; TOLL-LIKE RECEPTORS; VAGINA;

EID: 0345865243     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2004.01796.x     Document Type: Note

References (34)

1. Cates W. Priorities for sexually transmitted diseases in the late 1980s and beyond. Sex Transm Dis 1986; 13:114-7.
2. Piot P, Plummer FA, Mhalu FS, Lamboray JL, Chin J, Mann JM. AIDS. An international perspective. Science 1988; 239:573-9.
3. Peterman TA, Curran JW. Sexual transmission of human immunodeficiency virus. JAMA 1986; 256:2222-6.
4. Harris C, Small CB, Klein RS, Friedland GH, Moll B, Emeson EE, Spigland I, Steigbigel NH. Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome. N Engl J Med 1983; 308:1181-4.
5. Calabrese LH, Gopalakrishna KV. Transmission of HTLV-III infection from man to woman to man. N Engl J Med 1986; 314: 987.
6. Ho DD, Schooley RT, Rota TR, Kaplan JC, Flynn T, Salahuddin SZ, Gonda MA, Hirsh MS. HTLV-III in the semen and blood of a healthy homosexual man. Science 1984; 226:451-3.
7. Vogt MW, Craven DE, Crawford D, Witt D, Byington R, Schooley R, Hirsch MS. Isolation of HTLV-III from cervical secretions of woman at risk for AIDS. Lancet 1986; I:525-7.
8. Wofsy CB, Cohen JB, Hauer LB, Padian NS, Michaelis BA, Evans LA, Levy JA. Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet 1986; 1:527-9.
9. McDonough PG. Comment. Fert Steril 1987; 48:704.
10. Alexander NJ, Anderson DJ. Immunology of semen. Fert Steril 1987; 47:192-205.
11. Janeway CAJ, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20:197-216.
12. Janeway CAJ. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989; 54:1-13.
13. MacNeill C, Umstead TM, Phelps DS, Lin Z, Floros J, Shearer DA, Weisz J. Surfactant protein-A, an innate immune factor, is expressed in the vaginal mucosa and is present in vaginal lavage fluid. Immunology 2004; 111:99-107.
14. LeVine AM, Whitsett JA. Pulmonary collectins and innate host defense of the lungs. Microbes Infect 2001; 3:161-66.
15. Crouch E, Wright JR. Surfactant proteins a and d and pulmonary host defense. Annu Rev Physiol 2001; 63:521-54.
16. Phelps DS. Surfactant regulation of host defense function in the lung: a question of balance. Pediatr Pathol Mol Med 2001; 20: 269-92.
17. LeVine AM, Whitsett JA, Gwozdz JA, Richardson TR, Fisher JH, Burhans MS, Korfhagen TR. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 2000; 165:3934-40.
18. Brinker KG, Garner H, Wright JR. Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells. Am J Physiol Lung Cell Mol Physiol 2003; 284:L232-41.
19. Lawson PR, Reid KBM. Role of surfactant proteins A and D in innate immunity. Immunol Rev 2000; 173:66-78.
20. Ganz T. Defensins and host defense. Science 1999; 286:420-1.
21. Wira CR, Crane-Godreau M, Grant K. Endocrine regulation of the mucosal immune system in the female reproductive tract. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J, eds. Mucosal Immunology. San Diego, CA: Elsevier Inc., 2004: in press.
22. Wira CR, Fahey J, White HD, Yeaman GR, Given A, Howell A. The mucosal immune system in the human female reproductive tract: influence of stage of the menstrual cycle and menopause on mucosal immunity in the uterus. In: Glasser S, Aplin J, Guidice L, Tabibzadeh S (eds). The Endometrium. New York: Taylor & Francis, 2002:371-404.
23. Stolzenberg ED, Anderson GM, Ackermann MR, Whitlock RH, Zasloff M. Epithelial antibiotic induced in states of disease. Proc Natl Acad Sci USA 1997; 94:8686-90.
24. Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, Ganz T. Human β-defensin 1, an antimicrobial peptide of urogenital tissues. J Clin Invest 1998; 101:1633-42.
25. Zhao CQ, Wang I, Lehrer RI. Widespread expression of beta-defensin HBD-1 in human secretory glands and epithelial cells. FEBS Lett 1996; 396:319-22.
26. Quayle AJ, Martin Porter E, Nussbaum AA, Wang YM, Brabec C, Yip K-P, Mok SC. Gene expression, immunolocalization and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 1998; 152:1247-58.
27. Fichorova RN, Anderson DJ. Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod 1999; 60:508-14.
28. Hiemstra PS, Maassen RJ, Stolk J, Heinzel-Wieland R, Steffens GJ, Dijkman JH. Antibacterial activity of antileukoprotease. Infect Immun 1996; 64:4520-4.
29. McNeely T, Shugars D, Rosendahl M, Tucker C, Eisenberg S, Wahl S. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood 1997; 90:1141-9.
30. Wahl S, McNeely T, Janoff E, Shugars DC, Worley P, Tucker C, Orenstein JM. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-1. Oral Dis 1997; 3 (Suppl. 1):S64-9.
31. Moriyama A, Shimoya K, Ogata I et al. Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle. Mol Human Reprod 1999; 5: 656-61.
32. Draper D, Landers D, Krohn M, Hillier S, Weisenfeld H, Heine R. Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am J Obstet Gynecol 2000; 183:1243-8.
33. King AE, Critchley HOD, Kelly RW. Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role. Mol Human Reprod 2000; 6:191-6.
34. Fahey JV, Wira CR. Effect of menstrual status on anti-bacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J Infect Dis 2002; 185:1606-13.